Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03146650
Title Nivolumab and Ipilimumab in Treating Patients With Metastatic Recurrent Major or Minor Salivary Gland Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University

salivary gland carcinoma

salivary gland adenoid cystic carcinoma


Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.